Active projects

Slovak Research and Development Agency (SRDA):

PGP APVV-14-0334
Possible dual function of P-glycoprotein in leukemia cells: efflux pump and regulatory protein (2015-2018)
Principal investigator: Zdena Sulová
APVV-16-0439
The application of myrosinase for sulforaphane activation in development of a novel product exhibiting cancer prevention effects (2017-2021)
Principal Investigator (IMPG SAS): Zdena Sulová
PGP APVV-15-0303
Defense mechanisms of neoplastic cells against chemical stress (2016-2020)
Principal investigator (Faculty of Chemical and Food Technology STU in Bratislava): Albert Breier
Principal investigator at IMPG SAS: Zdena Sulová
APVV-15-0372
Novel synergistic antitumour properties of nuclear retinoid X receptor (RXR) agonists as a consequence of the conditional RXR-RAR heterodimer formation in human breast cancer cells (2016-2020)
Principal investigator (Institute of Experimental Endocrinology BMC SAS): Július Brtko
Principal investigator at IMPG SAS: Zdena Sulová
APVV-15-0641
Smart MoS2 platform for cancer diagnosis and targeted treatment (2016-2020)
Principal investigator (Institute of Physics SAS): Peter Šiffalovič
Principal investigator at IMPG SAS: Albert Breier
APVV-14-0753
Biochips and biosensors for glycorecognition, their development, preparation and application in cancer research (2015-2019)
Principal investigator (Institute of Chemistry, SAS): Jaroslav Katrlík
Principal investigator at IMPG SAS: Zdena Sulová

Grant Agency for Science (VEGA)

image VEGA 2/0057/18
Analyses of allele-specific regulation of CD33 expression (2018 – 2021)
Principal Investigator: Jana Královičová
VEGA 2/0157/18
The effect of polyphenols on the functions of signal proteins involved in proteins N-glycosylation in the endoplasmic reticulum of leukemia cells, depending on the expression of P-glycoprotein (2018-2021)
Principal Investigator: Viera Boháčová
PGP VEGA 2/0122/17
Study of changes in expression of some regulatory and functional proteins connected with the presence of P-gp protein in leukemic cells (2017-2020)
Principal investigator: Zdena Sulová
PGP VEGA 2/0156/16
The effect of endoplasmic reticulum stress inductors and proteaosome inhibitors on leukemia cell line L1210, SKM-1 and MOLM-13 with induced P-glycoprotein overexpression (2016-2018)
Principal investigator: Mário Šereš
PGP VEGA 2/0028/15
Changes of leukemia cells drug sensitivity induced by changes of membrane drug transporters expression profile (2015-2018)
Principal investigator: Albert Breier